Privacy settings

We use technical cookies, that are necessary for the management of the website, statistical cookies and marketing cookies (including third parties cookies) for displaying individual offers and ads. For more information read our Privacy Policy. Statistical cookies and marketing cookies (inclusive of third parties cookies) are used only with your consent. By clicking “Select all and agree” you consent to our use of statistical and/or marketing cookies (inclusive of third parties cookies).

To customize your privacy settings, tick your preferences in the checkboxes and click “Apply selection”. You can always change the privacy settings and deactivate cookies by following the instructions in the Privacy Policy.

Show preferences Select all and accept
IMA is loading

Main Financial Data 2010

Main Data: 31/12 Year 2010
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 503.27
– gross industrial income 202.24
– total operating cost 159.04
– operating profit 43.20
– net financial expenses 7.13
– group profit 17.00

 

Consolidated balance sheet Millions/Euro
– working capital 74.07
– non-current assets 166.91
– provision for severance indemnities and other provisions – 11.59
– net debt – 113.51
– equity pertaining to the group and minority interests 115.88

 

Other information Millions/Euro
– depreciation, amortization and impairment 16.10
– R & D costs 26.42

 

  Euro
Dividend per share 0.90

 

  No.
Employees 3,129

 

  Euro
Share capital 17,732,000

 

Main Data: 30/06 Year 2010
Consolidated income statement (international practice in accordance with IAS/IFRS) Millions/Euro
– total revenues 196.1
– gross industrial income 79.3
– total operating cost 77.6
– operating profit 1.7
– net financial expenses 3.0
– group profit (loss) – 1.3

 

Consolidated balance sheet Millions/Euro
– working capital 104.0
– non-current assets 160.5
– provision for severance indemnities and other provisions – 16.1
– net debt – 150.2
– equity pertaining to the group and minority interests 98.2

 

Other information Millions/Euro
– depreciation, amortization and impairment 6.4
– R & D costs 13.7

 

  No.
Employees 3,071

 

  Euro
Share capital 17,732,000

 

Net Sales by Sector: Year 2010
  Millions/Euro  
tea, herbs & coffee 87.61 17.4%
pharmaceuticals packaging 283.45 56.3%
pharmaceuticals processing 113.01 22.5%
other 19.20 3.8%
Total 503.27 100.0%

 

Net Sales by Country: Year 2010
  Millions/Euro  
E.U. (excluding Italy) 180.09 35.8%
Other European countries 37.01 7.3%
North America 72.77 14.5%
Asia & Middle East 131.00 26.0%
Other countries 40.34 8.0%
Total exports 461.21 91.6%
Italy 42.06 8.4%
Total 503.27 100.0%